ANDA 202114, held by Rising. Donepezil Hydrochloride.
As of Nov 16, 2026, ANDA 202114 (Donepezil Hydrochloride), held by Rising, was first approved by FDA on Jul 5, 2013, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 5, 2013 | Original application | Approved | None posted |
| Donepezil Hydrochloride5MG · tablet;oral | Donepezil Hydrochloride | Rx |
| Donepezil Hydrochloride10MG · tablet;oral | Donepezil Hydrochloride | Rx |
| Sep 21, 2020 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jul 5, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters